RMS Korea Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
RMS Korea Co., Ltd. - overview
Established
2009
Location
Yongin-si, Gyeonggido, South Korea
Primary Industry
Pharmaceuticals
About
RMS Korea Co. , Ltd. is a South Korean company specializing in pharmaceuticals, dental products, healthy aging solutions, and cosmetics, delivering innovative healthcare and beauty solutions to diverse customer segments. Founded in 2009, RMS Korea Co.
, Ltd. operates from Yongin-si, South Korea, focusing on health and beauty products. The company has engaged in a strategic investment with MatlinPatterson Global Advisers, raising KRW 24. 64 billion in a BUYOUT.
Seung-ho Ahn leads the company, contributing to its operational strategy. The firm has participated in one significant deal to date, demonstrating its capacity for growth and adaptation. RMS Korea provides a variety of products including innovative pharmaceuticals that target specific health issues, dental supplies for professionals and consumers, and cosmetics aimed at improving skin health. Their healthy aging solutions are designed for an aging population looking to enhance quality of life.
The company's offerings cater to healthcare providers, dental professionals, and consumers primarily within South Korea and select international markets. In 2012, RMS Korea reported a revenue of KRW 227,595,094. 20, with an EBITDA of KRW 2,901,607. 20.
Their revenue model is supported by direct sales to healthcare providers and partnerships with wholesalers and distributors, facilitating bulk orders from medical facilities and dental practices. RMS Korea plans to expand its product line with upcoming innovations in pharmaceuticals and cosmetics, targeting a release in the next two years. The company aims to enter new markets across Asia and Europe by 2025, leveraging the KRW 24. 64 billion raised from MatlinPatterson Global Advisers in 2007 to support these initiatives.
Current Investors
MatlinPatterson Global Advisers
Primary Industry
Pharmaceuticals
Sub Industries
Beauty & Hygiene, Pharmaceuticals
Website
www.rmskorea.com
Verticals
Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
RMS Korea Co., Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | RMS Korea Co., Ltd. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.